Actively Recruiting
A Phase 1 Study of S-1117
Led by Seismic Therapeutic AU Pty Ltd · Updated on 2025-03-12
96
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
S
Seismic Therapeutic AU Pty Ltd
Lead Sponsor
A
Avance Clinical Pty Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.
CONDITIONS
Official Title
A Phase 1 Study of S-1117
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Available for the entire study duration and follow-up
- Willing and able to comply with all study assessments and protocol requirements
- Voluntarily consents by signing the informed consent form
- Body mass index between 18 and 32 kg/m2 inclusive, and weight at least 45 kg
- In good physical and mental health as judged by the Investigator or delegate
You will not qualify if you...
- History of severe allergic or anaphylactic reaction
- Pregnant, nursing, or planning pregnancy or breastfeeding during the trial
- Known immunodeficiency disorder
- History of cancer except non-melanoma skin cancer
- History or positive test for HIV at screening
- Positive laboratory evidence of active hepatitis at screening
- Received live vaccine within 2 months before screening
- Any condition or prior therapy that may affect safety, compliance, or study completion as judged by the Investigator or delegate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CMAX Clinical Research
Adelaide, South Australia, Australia, 5000
Actively Recruiting
Research Team
S
Seismic Contact
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here